A total of 100 institutions have reported a stake in Inhibrx Biosciences, Inc. (NASDAQ:INBX) as of September 2025, according to recent 13F filings with the SEC.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| VIKING GLOBAL INVESTORS LP | 30 Sep, 2025 | 1,787,705 | 0 | 0.00% | $60,209,904.00 |
| PERCEPTIVE ADVISORS LLC | 30 Sep, 2025 | 1,327,707 | 349,815 | 35.77% | $44,717,171.00 |
| Sanofi | 30 Sep, 2025 | 1,157,926 | 0 | 0.00% | $38,998,948.00 |
| HighTower Advisors, LLC | 30 Sep, 2025 | 871,759 | 0 | 0.00% | $29,360,843.00 |
| BlackRock, Inc. | 30 Sep, 2025 | 684,746 | -43,998 | -6.04% | $23,062,245.00 |
| VANGUARD GROUP INC | 30 Sep, 2025 | 594,918 | -3,530 | -0.59% | $20,036,838.00 |
| MORGAN STANLEY | 30 Sep, 2025 | 442,856 | 415,048 | 1,492.55% | $14,915,390.00 |
| Sofinnova Investments, Inc. | 30 Sep, 2025 | 440,092 | -268,586 | -37.90% | $14,822,299.00 |
| Woodline Partners LP | 30 Sep, 2025 | 336,590 | -326,278 | -49.22% | $11,336,351.00 |
| MILLENNIUM MANAGEMENT LLC | 30 Sep, 2025 | 297,820 | 22,042 | 7.99% | $10,030,578.00 |
| PFM Health Sciences, LP | 30 Sep, 2025 | 239,644 | -4,617 | -1.89% | $8,071,210.00 |
| Caligan Partners LP | 30 Sep, 2025 | 236,383 | 236,383 | 0.00% | $7,961,379.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 30 Sep, 2025 | 221,920 | -4,035 | -1.79% | $7,476,072.00 |
| STATE STREET CORP | 30 Sep, 2025 | 203,923 | -1,036 | -0.51% | $6,868,127.00 |
| READYSTATE ASSET MANAGEMENT LP | 30 Sep, 2025 | 170,158 | 143,324 | 534.11% | $5,730,921.00 |
| KENNEDY CAPITAL MANAGEMENT LLC | 30 Sep, 2025 | 161,909 | -15,409 | -8.69% | $5,453,095.00 |
| Schonfeld Strategic Advisors LLC | 30 Sep, 2025 | 97,382 | -57,408 | -37.09% | $3,279,825.00 |
| NORTHERN TRUST CORP | 30 Sep, 2025 | 92,657 | -5,028 | -5.15% | $3,120,688.00 |
| BOOTHBAY FUND MANAGEMENT, LLC | 30 Sep, 2025 | 78,812 | 50,582 | 179.18% | $2,654,388.00 |
| Caption Management, LLC | 30 Sep, 2025 | 73,013 | -126,495 | -63.40% | $2,459,078.00 |